PER percheron therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4

  1. 87 Posts.
    lightbulb Created with Sketch. 52
    I like this part of the announcement...

    'Functional analysis results are due imminently with the cellular analysis to follow next month. Any applicable patent filings would be made ahead of disclosure of the results.'

    Are they hinting the results are looking good - so there are going to be delays in the announcement as we lodge a patent?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.8¢
Change
-0.001(5.88%)
Mkt cap ! $8.699M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $2.01K 251.2K

Buyers (Bids)

No. Vol. Price($)
9 4817091 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1969872 4
View Market Depth
Last trade - 15.47pm 04/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.